Our Review Summary
This first-person story — and its headline — claim to present new evidence to end any question about the life-saving, disease-preventing value of population-wide use of megadose multivitamin supplements. The second half of this 700-plus-word piece goes on to offer tips for purchasing supplements that are “high quality” brands, and warning consumers to avoid “cheaper” pills that might skimp on benefits or contain harmful ingredients. These “higher-quality” brands are conveniently available on the author’s linked website, making this story little more than an ad in the guise of news. Financial conflicts aside, the story’s claims about vitamin benefits are overstated and deceptive opinions based on cherry-picked studies, and the research described as “new” was actually published in 2012. More recent recommendations from the U.S. Preventive Services Task Force, based on a systematic review of all available clinical trials, conclude that there is “inadequate evidence to assess the balance of benefits and harms of supplements of single or paired vitamins, multivitamins, or minerals to prevent CVD or cancer.”
Why This Matters
Although good science tells us that taking a daily multivitamin is unlikely to be helpful, articles such as this one continue to confuse consumers. The multi-billion dollar supplement industry exploits that confusion to sell more products.
Criteria
Not Satisfactory
Although the article warns consumers away from “cheaper” products, it fails to disclose the costs of the suggested supplements. A back of the envelope calculation and a visit to a couple of national brand websites suggest the cost can run to $50 to $100 a month or more.
Not Satisfactory
The story includes claims of a number of benefits that are based mainly on the findings of the Physicians Health Study II (PHS II), a multivitamin supplement trial that involved middle-aged men. There are a number of problems with the way the story describes these results:
- The story claims that 68,000 cancers a year could be prevented with daily supplement use, and that multivitamins “lowered cancer risk by 27 percent among men with a history of cancer and by 8 percent among men with no history of the disease.” The story doesn’t present these benefits in terms of absolute risk reduction, which are more meaningful. The original study notes that there were 1.3 fewer cancer cases annually for every 1,000 men taking supplements (17.0 vs. 18.3 cases per 1000 person-years in the multivitamin group compared with the control group.)
- The story claims that there’s “there’s no reason to assume this [cancer benefit] doesn’t apply to women as well.” In fact, there’s very good reason to believe this. Other multivitamin studies that have enrolled women found no such cancer benefit. Extrapolating this benefit to women is totally unjustified and misleading.
- According to the headline, “One [multivitamin] may actually save your life.” But the PHS II found no benefit on cancer-related deaths or total deaths in the study. There was a very small reduction in the number of cancer diagnoses (not deaths) among men who took the supplements in PHS II.
- The story claims dosages of 2,500 percent of your daily value “is going to give you more of what you actually need to feel good.” The PHS II, however, used a low-dose supplement that contained around 100% of daily values — the “typical” type of vitamin that the story derides as inferior.
Not Satisfactory
The article is dismissive about reports of any potential harms of supplementation in otherwise healthy people, except to note that when people buy supplements, they would do well to “avoid toxic fillers” consisting of “cheap additives.” In other words, no worries if you buy the expensive brands. In fact, there are studies describing harmful effects of supplements, particularly doses that are many times the recommended daily requirement suggested by ethical nutritionists and scientific organizations. The story also suggests that the consumer “look for” specific formulations of vitamins, including beta carotene — a supplement which is known to increase cancer risk among smokers in high quality studies.
Not Satisfactory
The story goes the extra mile to describe the possible benefits of supplements, and to discuss the value of one of the studies as randomized and controlled. But it does not say a word about the limitations of the analyses cited in the article, or balance the piece with data from other high-quality studies. After systematically reviewing all available trials of reasonably good quality on vitamin supplementation, a team of experts from the US Preventive Services Task Force concluded that “current evidence is insufficient to assess the balance of benefits and harms of multivitamins for the prevention of cardiovascular disease or cancer.” This story badly needed this perspective.
Not Satisfactory
This story hypes the benefits of vitamins for just about everything. To read this article is to believe that most of us (actually the article says “everyone”) had better run right to the vitamin supplement aisle or have only ourselves to blame for failing to “thrive,” as well as for cancer, heart disease, dementia and other diseases. There are indeed people who have actual nutritional deficiencies, owing to illness and poverty, for example. But to suggest that virtually everyone is in urgent need of supplements is over the top.
Not Satisfactory
The story is essentially one doctor’s pitch for consumers to buy her personalized line of supplements. We address the story’s many ethical challenges in this blog post.
Not Satisfactory
The story never mentions eating fresh, healthier foods or other lifestyle modifications as alternatives to supplements in preventing disease (e.g. exercise, weight loss, or cancer screening). Further, the story inexplicably dismisses generic low-dose vitamins as an inadequate method of attaining health benefits. In fact, the best evidence available favors these low-dose vitamins — not the high doses favored by the author.
Not Applicable
The availability of vitamin supplements is not in question.
Not Satisfactory
The headline and article suggest that the debate about the value of supplements is now over, and that the information cited in the piece is all new and previously unreported. Neither is the case. The supposedly “new” study that the story cites as appearing in the January 2015 edition of the journal Postgraduate Medicine was actually published in JAMA in October, 2012. The Postgraduate Medicine article is merely a review of that and other studies. The story doesn’t acknowledge the existence of more recent and comprehensive analyses of the evidence on vitamin supplements.
Satisfactory
Although there are no independent sources, the story does cite two different studies related to vitamins, suggesting it wasn’t based entirely on a press release.
Total Score: 1 of 9 Satisfactory
Comments (1)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
matt
February 3, 2015 at 10:32 amAgree – this is a pretty bad article. It uses weak evidence for multivitamins as essentially strong evidence, dismisses strong evidence that contradicts it, but then also promotes some nonsense about toxins in the pill being harmful. Yikes.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like